Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lowell Anthony

Showing results (21-30 of 45) with videos related to

Pageof 5
Sort By:
The American Surgeon|September 11, 2002
Cytoreductive surgery in patients with advanced-stage carcinoid tumorsSeza A Gulec, Timothy S Mountcastle, Daniel Frey, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|May 23, 2006
Elevation of serum riboflavin carrier protein in hepatocellular carcinomaPrakash N Rao, Jeffrey Crippin, Edward Levine, et al.
Journal of Gastrointestinal Oncology|October 12, 2019
Does the addition of adjuvant intraoperative tumor bed chemotherapy during midgut neuroendocrine tumor debulking procedures benefit patients?Yi-Zarn Wang, Aman Chauhan, Robert A Ramirez, et al.
BMC Cancer|May 21, 2021
Can an amino acid mixture alleviate gastrointestinal symptoms in neuroendocrine tumor patients?Aman Chauhan, Satya Das, Rachel Miller, et al.
Journal of the American College of Surgeons|March 25, 2014
A single institution's experience with surgical cytoreduction of stage IV, well-differentiated, small bowel neuroendocrine tumorsJ Philip Boudreaux, Yi-Zarn Wang, Anne E Diebold, et al.
Cancer Biotherapy & Radiopharmaceuticals|July 3, 2008
Safety and efficacy of radionuclide therapy with high-activity In-111 pentetreotide in patients with progressive neuroendocrine tumorsEbrahim S Delpassand, Jennifer Sims-Mourtada, Hitomi Saso, et al.
Cancers|February 25, 2022
hPG<sub>80</sub> (Circulating Progastrin), a Novel Blood-Based Biomarker for Detection of Poorly Differentiated Neuroendocrine Carcinoma and Well Differentiated Neuroendocrine TumorsAman Chauhan, Alexandre Prieur, Jill Kolesar, et al.
Journal of Oncology|June 2, 2018
Capecitabine and Temozolomide in Neuroendocrine Tumor of Unknown PrimaryAman Chauhan, Zainab Farooqui, Le Aundra Murray, et al.
Oncotarget|August 28, 2020
Post FDA approval analysis of 200 gallium-68 DOTATATE imaging: A retrospective analysis in neuroendocrine tumor patientsAman Chauhan, Riham El-Khouli, Timothy Waits, et al.
Journal of Patient-Reported Outcomes|October 28, 2019
Evaluation of meaningful change in bowel movement frequency for patients with carcinoid syndromeStacie Hudgens, John Ramage, Matthew Kulke, et al.
Pageof 5

Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
The American Surgeon|September 11, 2002
Cytoreductive surgery in patients with advanced-stage carcinoid tumorsSeza A Gulec, Timothy S Mountcastle, Daniel Frey, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|May 23, 2006
Elevation of serum riboflavin carrier protein in hepatocellular carcinomaPrakash N Rao, Jeffrey Crippin, Edward Levine, et al.
Journal of Gastrointestinal Oncology|October 12, 2019
Does the addition of adjuvant intraoperative tumor bed chemotherapy during midgut neuroendocrine tumor debulking procedures benefit patients?Yi-Zarn Wang, Aman Chauhan, Robert A Ramirez, et al.
BMC Cancer|May 21, 2021
Can an amino acid mixture alleviate gastrointestinal symptoms in neuroendocrine tumor patients?Aman Chauhan, Satya Das, Rachel Miller, et al.
Journal of the American College of Surgeons|March 25, 2014
A single institution's experience with surgical cytoreduction of stage IV, well-differentiated, small bowel neuroendocrine tumorsJ Philip Boudreaux, Yi-Zarn Wang, Anne E Diebold, et al.
Cancer Biotherapy & Radiopharmaceuticals|July 3, 2008
Safety and efficacy of radionuclide therapy with high-activity In-111 pentetreotide in patients with progressive neuroendocrine tumorsEbrahim S Delpassand, Jennifer Sims-Mourtada, Hitomi Saso, et al.
Cancers|February 25, 2022
hPG<sub>80</sub> (Circulating Progastrin), a Novel Blood-Based Biomarker for Detection of Poorly Differentiated Neuroendocrine Carcinoma and Well Differentiated Neuroendocrine TumorsAman Chauhan, Alexandre Prieur, Jill Kolesar, et al.
Journal of Oncology|June 2, 2018
Capecitabine and Temozolomide in Neuroendocrine Tumor of Unknown PrimaryAman Chauhan, Zainab Farooqui, Le Aundra Murray, et al.
Oncotarget|August 28, 2020
Post FDA approval analysis of 200 gallium-68 DOTATATE imaging: A retrospective analysis in neuroendocrine tumor patientsAman Chauhan, Riham El-Khouli, Timothy Waits, et al.
Journal of Patient-Reported Outcomes|October 28, 2019
Evaluation of meaningful change in bowel movement frequency for patients with carcinoid syndromeStacie Hudgens, John Ramage, Matthew Kulke, et al.
Pageof 5